SG3 Management, LLC
- SEC CIK
- 0001630888
- Latest filing
- Nov 15, 2023
RARE holding history
Ultragenyx Pharmaceutical Inc. in every 13F filed by SG3 Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RARE overviewAll 13F holders of RAREFull Q3 2023 holdings
- Shares (Q4 2022)
- 0
- Sold out in Q4 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 3
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 0 | $0 | 0.0% | −32,173−100.0% | Sold out | Holders |
| Q3 2022 | 32,173 | $1.33M | 0.8% | +32,173 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,952−100.0% | Sold out | Holders |
| Q1 2022 | 10,952 | $795.0K | 0.2% | +10,952 | New | Holders |
| Q3 2021 | 0 | $0 | 0.0% | −4,000−100.0% | Sold out | Holders |
| Q2 2021 | 4,000 | $381.0K | 0.2% | +4,000 | New | Holders |